CD4 and melanoma: Reduction of Dbp and E2f8 expression in CD4+ T cells respectively decreases and increases IL-9 production, and this decrease and increase respectively enhance and suppress tumor growth when the genetically engineered CD4+ T cells are adoptively transferred into the Rag1−/− mice bearing the melanoma and fibrosarcoma.